Literature DB >> 752027

The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia.

I A Hughes, J S Winter.   

Abstract

Simultaneous determinations of serum concentrations of 17OH-progesterone, testosterone, androstenedione, and progesterone, and of urinary excretion of 17-ketosteroids and pregnanetriol have been performed at intervals in 31 patients with the C21-hydroxylase form of congenital adrenal hyperplasia. In prepubertal patients there were highly significant correlations between levels of 17OH-progesterone and those of testosterone, androstenedione, and progesterone, respectively. Similar correlations were observed in adolescent girls. In adolescent boys rising 17OH-progesterone levels were reflected by increasing levels of androstenedione and progesterone, but there was no change in serum testosterone concentrations. Levels of serum 17OH-progesterone below 200 ng/dl were uniformly associated with normal serum concentrations of testosterone, androstenedione, and progesterone, and normal urinary 17-ketosteroid and pregnanetriol excretion. In contrast, levels above 1000 ng/dl were accompanied by increased levels of the other steroids except in adolescent males; in this group the finding of unchanging serum testosterone concentrations in spite of rising 17OH-progesterone levels presumably indicates that testosterone of adrenal origin causes suppression of testicular testosterone production, either through a direct effect upon Leydig cells or via suppression of LH release.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 752027     DOI: 10.1210/jcem-46-1-98

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Circadian patterns of plasma steroids in congenital adrenal hyperplasia.

Authors:  I A Hughes
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

2.  Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.

Authors:  Kyriakie Sarafoglou; John H Himes; Jean M Lacey; Brian C Netzel; Ravinder J Singh; Dietrich Matern
Journal:  Horm Res Paediatr       Date:  2010-08-25       Impact factor: 2.852

3.  17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.

Authors:  K von Schnakenburg; F Bidlingmaier; D Knorr
Journal:  Eur J Pediatr       Date:  1980-05       Impact factor: 3.183

4.  Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.

Authors:  H Frisch; K Parth; E Schober; W Swoboda
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

5.  Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia.

Authors:  I A Hughes; A Wilton; C A Lole; O P Gray
Journal:  Arch Dis Child       Date:  1979-05       Impact factor: 3.791

6.  Androstenedione rhythms in saliva in congenital adrenal hyperplasia.

Authors:  M C Young; R F Walker; D Riad-Fahmy; I A Hughes
Journal:  Arch Dis Child       Date:  1988-06       Impact factor: 3.791

7.  Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia.

Authors:  Andrew Dauber; Henry A Feldman; Joseph A Majzoub
Journal:  Int J Pediatr Endocrinol       Date:  2010-09-14

8.  The Range of 2.2-3.3 mg/gCr of Pregnanetriol in the First Morning Urine Sample as an Index of Optimal Control in CYP21 Deficiency.

Authors:  Masako Izawa; Keiko Aso; Asako Higuchi; Daisuke Ariyasu; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2008-08-08

9.  Pregnanetriol in the Range of 1.2-2.1 mg/m(2)/day as an Index of Optimal Control in CYP21A2 Deficiency.

Authors:  Masako Izawa; Keiko Aso; Asako Higuchi; Daisuke Ariyasu; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2007-05-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.